Drug Delivery Device with Intravesical Tolerability
AssigneeTARIS Biomedical LLC
InventorsMichael J. Cima, Heejin Lee
Life of this patent
Estimating the term…
Loading patent…
AssigneeTARIS Biomedical LLC
InventorsMichael J. Cima, Heejin Lee
Estimating the term…
Intravesical devices are provided that are wholly deployable within the bladder of a patient in need of treatment and are well tolerated by the patient. The device may include an elastic body having a retention shape having (i) dimensions that provide intravesical mobility and that prevent voiding of the medical device through the urethra, and (ii) dimensions, buoyancy, or both, that exclude the medical device from entering the orifices of the ureters. The elastic body may exert a maximum acting force less than 1 N when compressed to a shape with a maximum dimension in any dimension of 3 cm. The device may include a drug for controlled release within the bladder, for treatment of the bladder or a regional tissue. Methods of treatment are also provided that include selecting a patient in need of treatment in the bladder where tolerability of the treatment is a primary concern.
An intravesical drug delivery system comprising:
An intravesical drug delivery system comprising:
The intravesical drug delivery system of 10, which is configured to permit the plurality of mini-tablets to be solubilized in vivo and to release the FGFR3-selective tyrosine kinase inhibitor, by diffusion through a wall of the polymeric body bounding the drug reservoir lumen.
Dependencies are inferred from the claim text.